Related Experiment Video
Updated: Aug 15, 2026

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
Published on: April 9, 2018
C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of
Ramona S Scotland1, Marc Cohen, Paul Foster
1Wolfson Institute for Biomedical Research, University College London, Cruciform Building, Gower Street, London WC1E 6AE, United Kingdom.
Insights
C-type natriuretic peptide (CNP) reduces inflammation by inhibiting immune cell and platelet activation in blood vessels. This peptide may offer a therapeutic target for cardiovascular disorders.
Area of Science:
- Cardiovascular Research
- Inflammation Biology
- Endothelial Cell Biology
Background:
- Immune cell recruitment is crucial for inflammation and cardiovascular disease pathogenesis.
- C-type natriuretic peptide (CNP) is an endothelium-derived mediator regulating vascular tone and protecting against ischemia/reperfusion injury.
Purpose of the Study:
- To investigate if CNP inhibits leukocyte recruitment and platelet aggregation.
- To determine CNP's anti-inflammatory influence on the blood vessel wall.
Main Methods:
- Assessed CNP effects on leukocyte-endothelial cell interactions in mouse mesenteric venules in vivo.
- Utilized endothelial nitric oxide synthase knockout (eNOS(-/-)) mice and IL-1beta/histamine-induced inflammation models.
- Examined CNP's impact on platelet aggregation and P-selectin expression in human blood and endothelial cells.
Main Results:
- CNP rapidly suppressed leukocyte rolling in eNOS(-/-) mice and IL-1beta/histamine-induced inflammation.
- CNP inhibited platelet-leukocyte interactions and thrombin-induced platelet aggregation.
- CNP selectively attenuated P-selectin expression on endothelial cells, leukocytes, and platelets.
Conclusions:
- CNP modulates acute inflammation in the blood vessel wall by inhibiting leukocyte and platelet activation.
- CNP's anti-inflammatory effects are partly mediated by suppressing P-selectin expression.
- Endothelial CNP may possess anti-atherogenic properties and represent a therapeutic target for cardiovascular disorders.
Abstract:
The multifaceted process of immune cell recruitment to sites of tissue injury is key to the development of an inflammatory response and involved in the pathogenesis of numerous cardiovascular disorders. We recently identified C-type natriuretic peptide (CNP) as an important endothelium-derived mediator that regulates vascular tone and protects against myocardial ischemia/reperfusion injury. Herein, we investigated whether CNP inhibits leukocyte recruitment and platelet aggregation and thereby exerts a potential antiinflammatory influence on the blood vessel wall. We assessed the effects of CNP on leukocyte-endothelial cell interactions in mouse mesenteric postcapillary venules in vivo in animals with high basal leukocyte activation (endothelial nitric oxide synthase knockout mice, eNOS(-/-)) or under acute inflammatory conditions (induced by interleukin-1beta or histamine). CNP suppressed basal leukocyte rolling in eNOS(-/-) mice in a rapid, reversible, and concentration-dependent manner. These effects of CNP were mimicked by the selective natriuretic peptide receptor-C agonist cANF(4-23). CNP also suppressed leukocyte rolling induced by IL-1beta or histamine, inhibited platelet-leukocyte interactions, and prevented thrombin-induced platelet aggregation of human blood. Furthermore, analysis of human umbilical vein endothelial cells, leukocytes, and platelets revealed that CNP selectively attenuates expression of P-selectin. Thus, CNP is a modulator of acute inflammation in the blood vessel wall characterized by leukocyte and platelet activation. These antiinflammatory effects appear to be mediated, at least in part, via suppression of P-selectin expression. These observations suggest that endothelial CNP might maintain an anti-atherogenic influence on the blood vessel wall and represent a target for therapeutic intervention in inflammatory cardiovascular disorders.
More Related Videos
12:55A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
Published on: December 9, 2021
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
Related Concept Videos
Selectins
Acute Inflammation II: Cellular Phase
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Nitric Oxide Signaling Pathway
Inflammation
Acute Inflammation III: Local and Systemic Effects